A detailed history of Gateway Investment Advisers LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 1,352 shares of UTHR stock, worth $504,147. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,352
Previous 1,352 -0.0%
Holding current value
$504,147
Previous $430,000 12.56%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$228.26 - $319.04 $89,934 - $125,701
394 Added 41.13%
1,352 $430,000
Q1 2024

Apr 12, 2024

BUY
$210.76 - $249.51 $201,908 - $239,030
958 New
958 $220,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Gateway Investment Advisers LLC Portfolio

Follow Gateway Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.